CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 369 enrolled
Drug / intervention
Blood collection +2 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01691820
NCT01691820N/ACompleted
CompareCT.gov

A Study in Adolescent Females to Explore Cytomegalovirus Infection

GlaxoSmithKline·interventional·Posted Sep 25, 2012·Updated Apr 27, 2021

In Brief

A clinical study evaluating Blood collection, Urine collection, and 1 other intervention for Infections, Cytomegalovirus. Completed, enrolled 369 participants across 5 sites in 3 countries.

Detailed Summary

The purpose of this study is to estimate the incidence of Cytomegalovirus (CMV) secondary infections (re-infections/re-activations) and the incidence of CMV primary infections in adolescent females.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfections, Cytomegalovirus
CountriesFinland, Mexico, United States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedSep 25, 2012
Enrollment StartOct 5, 2012
Primary CompletionApr 8, 2017
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 13.8 years ago

Interventions

Blood collectionprocedure

Samples collected at Months 0, 4, 8, 12, 16, 20, 24, 28, 32, and 36.

Urine collectionprocedure

Samples collected at Months 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, and 36.

Saliva collectionprocedure

Samples collected at Months 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, and 36.